The PornLoS Treatment Program: Study protocol of a new psychotherapeutic approach for treating pornography use disorder.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stark Rudolf, Markert Charlotte, Golder Sarah, Psarros Rhea, Discher Julian P, Khatib Said, Metzger Julia, Palmer Sebastian, Rechmann Johanna, Storz Florian, Walter Bertram, Allard Sarah, Antons Stephanie, Bledzka Marta, Brand Matthias, Dörrenbächer Sandra, Englisch Julia, Friehs Thilo, Da Cunha Gonçalves Katja, Haberkamp Anke, Hall Mila, Kananian Schahryar, Kemmerer Pascal, Klingelhöfer Doerthe, Lutz Wolfgang, Melzig Christiane A, Michael Tanja, Neumann Anja, Neusser Silke, Niemann Anja, Odenthal Michael, Rubel Julian, Schlierenkamp Sarah, Speckemeier Christian, Ünlü Luisa, Vogt Rabea, Wölfling Klaus, Zachariassen Wiebke, Zur Hausen Gerrit, Heinz Christine
Аннотация
METHODS: This article provides an overview of the manualized short-term PornLoS Treatment Program (Pornografienutzungsstörung effektiv behandeln- Leben ohne Suchtdruck; translation: Treating pornography use disorder effectively - life without craving). The program combines 24 individual and 6 group psychotherapy sessions with an interdisciplinary approach by offering a novel treatment framework. This includes, e.g., a mobile app, establishment of self-help groups, and access to other social services such as couple counseling. The cognitive-behavioral treatment program contains interventions addressing psychoeducation, cue exposure, impulse control, cognitive restructuring, emotional regulation, and relapse management.We here also describe the study protocol of an ongoing four-arm randomized controlled trial. The aim is to test two variants of the PornLoS Treatment Program differing with respect to their treatment goal (abstinence or reduced pornography use) against cognitive-behavioral treatment as usual and against a waitlist control group. The primary outcome is the absence of a PUD diagnosis at the end of therapy. The total target sample size will comprise n = 316 patients with PUD across eight study sites.
RESULTS: The results will be presented at international conferences and published in a scientific peer-reviewed journal.